文献速递神经MR

黑血MRI血管壁强化可预测脑淀粉样血管病患者的急性与未来卒中

Vessel Wall Enhancement on Black-Blood MRI Predicts Acute and Future Stroke in Cerebral Amyloid Angiopathy.
PubMed 文献 · AJNR Am J Neuroradiol · 2021-03-18

回顾性研究纳入50例脑淀粉样血管病患者,评估3T黑血血管壁MRI强化与急性及未来缺血性卒中的关系。血管壁强化与急性缺血性卒中相关(患病率比1.5),强化阳性患者无卒中生存期更短。

要点

  • 脑淀粉样血管病患者黑血MRI血管壁强化与急性缺血性卒中相关,患病率比1.5。
  • 血管壁强化阳性患者未来缺血性卒中风险更高,无卒中生存率63.9%对32.2%。
  • 血管壁强化评估的校正Kappa值为0.82,提示观察者间一致性良好。

关键影像表现/征象

  • 血管壁强化在增强前后血流抑制3D T1WI上检测,50例中29例(58.0%)存在血管壁强化。
  • 50例中35例(70.0%)伴有缺血性卒中。

诊断标准与关键数值

  • 血管壁强化预测急性缺血性卒中的最终回归模型包括血管壁强化(患病率比1.5,95%CI 1.1-2.2,P=.022)、年龄(患病率比1.02,95%CI 1.0-1.05,P=.036)、症状至MR时间(患病率比0.9,95%CI 0.8-0.9,P<.001)和吸烟(患病率比0.7,95%CI 0.5-1.0,P=.042),c-statistic=0.92(95%CI 0.84-0.99)。
  • 预测未来缺血性卒中的最终模型c-statistic=0.70,包括初始缺血性卒中(风险比3.4,95%CI 1.0-12.0,P=.053)和血管壁强化(风险比2.5,95%CI 0.9-7.0,P=.080)。
  • 血管壁强化评估的患病率与偏倚校正Kappa值为0.82(95%CI 0.71-0.93)。

临床应用与阅片要点

  • 在脑淀粉样血管病患者中,黑血MRI血管壁强化可用于评估急性缺血性卒中风险。
  • 血管壁强化阳性患者未来缺血性卒中风险更高,无卒中生存率63.9%(95%CI 43.2%-84.0%)对32.2%(95%CI 14.4%-62.3%),卡方=4.9,P=.027。
  • 未来缺血性卒中在脑淀粉样血管病中的年发生率为49.7%(95%CI 34.5%-67.2%),总风险时间37.5人年。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Cerebral amyloid angiopathy (CAA) is a known risk factor for ischemic stroke though angiographic imaging is often negative. Our goal was to determine the relationship between vessel wall enhancement (VWE) in acute and future ischemic stroke in CAA patients.

MATERIALS AND METHODS: This was a retrospective study of patients with new-onset neurologic symptoms undergoing 3T vessel wall MR imaging from 2015 to 2019. Vessel wall enhancement was detected on pre- and postcontrast flow-suppressed 3D T1WI. Interrater agreement was evaluated in cerebral amyloid angiopathy-positive and age-matched negative participants using a prevalence- and bias-adjusted kappa analysis. In patients with cerebral amyloid angiopathy, multivariable Poisson and Cox regression were used to determine the association of vessel wall enhancement with acute and future ischemic stroke, respectively, using backward elimination of confounders to P < .20.

RESULTS: Fifty patients with cerebral amyloid angiopathy underwent vessel wall MR imaging, including 35/50 (70.0%) with ischemic stroke and 29/50 (58.0%) with vessel wall enhancement. Prevalence- and bias-corrected kappa was 0.82 (95% CI, 0.71-0.93). The final regression model for acute ischemic stroke included vessel wall enhancement (prevalence ratio = 1.5; 95% CI, 1.1-2.2; P = .022), age (prevalence ratio = 1.02; 95% CI, 1.0-1.05; P = .036), time between symptoms and MR imaging (prevalence ratio = 0.9; 95% CI, 0.8-0.9; P < .001), and smoking (prevalence ratio = 0.7; 95% CI, 0.5-1.0; P = .042) with c-statistic = 0.92 (95% CI, 0.84-0.99). Future ischemic stroke incidence with cerebral amyloid angiopathy was 49.7% (95% CI, 34.5%-67.2%) per year over a total time at risk of 37.5 person-years. Vessel wall enhancement-positive patients with cerebral amyloid angiopathy demonstrated significantly shorter stroke-free survival with 63.9% (95% CI, 43.2%-84.0%) versus 32.2% (95% CI, 14.4%-62.3%) ischemic strokes per year, chi-square = 4.9, P = .027. The final model for future ischemic stroke had a c-statistic of 0.70 and included initial ischemic stroke (hazard ratio = 3.4; 95% CI, 1.0-12.0; P = .053) and vessel wall enhancement (hazard ratio = 2.5; 95% CI, 0.9-7.0; P = .080).

CONCLUSIONS: Vessel wall enhancement is associated with both acute and future stroke in patients with cerebral amyloid angiopathy.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. McNally JS, Sakata A, Alexander MD, et al. Vessel Wall Enhancement on Black-Blood MRI Predicts Acute and Future Stroke in Cerebral Amyloid Angiopathy. AJNR Am J Neuroradiol. 2021. PMID: 33737266. doi:10.3174/ajnr.A7047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。